Abiopharma

New Form 144 - Phreesia, Inc. Filed: 2025-08-27 AccNo: 0001959173-25-005585 Size: 5 KB

Hemrajani Rekha 🔴 sold 10.7K shares of MAXCYTE, INC. (MXCT) at $2.09 Transaction Date: Jun 25, 2025 | Filing ID: 003155

New Form 3 - Rezolute, Inc. Filed: 2025-08-27 AccNo: 0000912282-25-000932 Size: 5 KB

New Form 144 - Medpace Holdings, Inc. Filed: 2025-08-27 AccNo: 0001969223-25-000675 Size: 5 KB

Travere Therapeutics Announces U.S. FDA Approves REMS Modification for FILSPARI® (sparsentan) in IgA Nephropathy

New Form 8-K - PHIBRO ANIMAL HEALTH CORP Filed: 2025-08-27 AccNo: 0001558370-25-011778 Size: 923 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Kooij Louise Frederika 🔴 sold 8.3K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $24.86 Transaction Date: Aug 25, 2025 | Filing ID: 111738

New Form 424B3 - Phio Pharmaceuticals Corp. Filed: 2025-08-27 AccNo: 0001683168-25-006496 Size: 131 KB

Tilray Brands Successfully Regains Compliance withNasdaq’s Minimum Bid Price Requirement

New Form 8-K - CARDINAL HEALTH INC Filed: 2025-08-27 AccNo: 0001193125-25-189845 Size: 524 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits

New Form 3 - DANAHER CORP /DE/ Filed: 2025-08-27 AccNo: 0000313616-25-000176 Size: 9 KB

New Form 6-K - Zentek Ltd. Filed: 2025-08-27 AccNo: 0001062993-25-015004 Size: 24 KB

Tarsus to Participate in Upcoming Investor Conferences

Bhatt Padmanabh P. 🟡 adjusted position in 581 shares (1 derivative) of SUPERNUS PHARMACEUTICALS, INC. (SUPN) at $41.46 Transaction Date: Aug 25, 2025 | Filing ID: 000004

New Form 8-K - Aptose Biosciences Inc. Filed: 2025-08-27 AccNo: 0001193125-25-189841 Size: 132 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers